ERBB2 and breast carcinoma: In this study, we aim to assess accuracy and variability of survival extrapolations using SPD models and EH models, with and without assuming cure, using survival data on HER2-positive breast cancer patients from the National Breast Cancer Register of Sweden (NBCR).